Log in to save to my catalogue

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response Afte...

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response Afte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1859466102

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

About this item

Full title

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Publisher

United States: Oxford University Press

Journal title

Clinical infectious diseases, 2017-01, Vol.64 (1), p.44-52

Language

English

Formats

Publication information

Publisher

United States: Oxford University Press

More information

Scope and Contents

Contents

Background. The development of direct-acting antivirals in recent years has dramatically enhanced rates of viral eradication to >90% in patients with chronic hepatitis C virus (HCV) infection. To determine true treatment efficacy and define the most appropriate retreatment, it is important to distinguish virologic relapse from reinfection when pati...

Alternative Titles

Full title

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1859466102

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1859466102

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/ciw676

How to access this item